Frontiers in Medicine-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=1234897, encodeId=f07d123489e0a, content=审稿速度:24.0 | 投稿命中率:5.0 偏重的研究方向：111 经验分享：1111, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=120b6405718, createdName=ms7000000694942772, createdTime=Tue Jul 26 16:12:06 CST 2022, time=2022-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226722, encodeId=8f511226e22e8, content=6-9写了撤稿信，系统回复十天左右会回复邮件，后面又发过撤稿信，被网易退回邮件，互动评审已经激活，出现了三个审稿人，有两人提了一点拼写，增加参考文献要求然后结束审稿，有一个提了十条修改意见，让我修回，我到底该咋办，预警期刊资源不报版面费。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ebd8125048, createdName=茂茂梧桐, createdTime=Thu Jun 16 07:07:43 CST 2022, time=2022-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1201753, encodeId=7ca11201e53f5, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：流行病学 经验分享：文章接受了，但是上预警期刊了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=df116455260, createdName=ms3000000556942775, createdTime=Fri Mar 11 18:36:13 CST 2022, time=2022-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212720, encodeId=33a61212e2003, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：临床研究 经验分享：审稿速度快，可能是题目比较符合审稿人口味，一个小修，一个接受，感觉预警没影响，还是比较香的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0de5602870, createdName=吉非替尼子, createdTime=Tue Apr 19 23:55:29 CST 2022, time=2022-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208726, encodeId=df4e1208e2672, content=审稿速度:1.0 | 投稿命中率:95.0 经验分享：感觉还是真香, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=40785484359, createdName=ms2000001198602593, createdTime=Tue Apr 05 10:58:23 CST 2022, time=2022-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207711, encodeId=14ef120e7118c, content=偏重的研究方向：临床医学 经验分享：稿件见刊近半年后惊闻上了中科院预警名单？！感觉不大理解……突然的预警有点坑人啊~ 当时投的是临床回顾性研究，三个审稿人，一个拒稿两个建议大修，编辑决定让我大修并且必须把三个审稿人的问题逐条回答，平均下来每个人提出来的问题在15条上下，而且有的问题确实很尖锐，想破脑袋才自觉勉强回答得可以。期间向编辑发邮件请求延期修回（杂志社给的时间太紧了只放半个月），对方也很nice地同意延长到一个月。从投稿到接收大概花了有4个月左右。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26fc5490985, createdName=ms5000001509020786, createdTime=Fri Apr 01 00:32:35 CST 2022, time=2022-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084388, encodeId=ec6b10843883b, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：脑卒中 经验分享：我在6.18投稿，等了2个月没有审稿，换到另一个主题，2个审稿人审了3个月，12.07接受，12.20完成proof。但是不知道多久会online？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM632og6BGtgCG36JyHOMDAz5d9M72Gojw7d2YxlmgicSQ1v7JAaZz9WxwwVKArEMvSicpuRIyEibtSsJzUQqZ9fzzuMZak2WWKAs8/0, createdBy=a63a1933845, createdName=L/风, createdTime=Sun Dec 26 12:24:05 CST 2021, time=2021-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184327, encodeId=e904118432ef4, content=Review Finailed都一个多月了编辑都没有消息，催了两次也没回。两个审稿人endorsed的都很快。这编辑也是无语了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d2595112466, createdName=1461a9cfm23暂无昵称, createdTime=Fri Jan 14 19:33:52 CST 2022, time=2022-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071114, encodeId=fa3b10e111423, content=做的纯生信的，投稿一周让转投到frontiers in Oncology ，感觉要被拒，但还是同意了，因为实在不知道哪里还能生信灌水了……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210909/7146f1426c1e49bbb98d94637759e71f/7d17fd3269ca410d895702092f504459.jpg, createdBy=ac155115075, createdName=一只虫虫, createdTime=Wed Nov 17 15:10:47 CST 2021, time=2021-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179946, encodeId=46dc11e994649, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：2021年12月31被中科院列为低度预警期刊，仔细查了一下，该杂志国人占比和自引率都比较低，上榜的原因可能是扩刊问题，2019年300左右，2020接近1000篇，2021目测2000左右，同时对比了下其他的frontiers的杂志基本都存在扩刊严重的问题。目前一篇临床小文章刚让修稿，自己想重投但老板不想撤，纠结中。不知道各位怎么看。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a5e86444183, createdName=ms8000001802186405, createdTime=Mon Jan 03 09:52:08 CST 2022, time=2022-01-03, status=1, ipAttribution=)]

2022-07-26 ms7000000694942772

审稿速度:24.0 | 投稿命中率:5.0
偏重的研究方向：111
经验分享：1111

41 0

[GetPortalCommentsPageByObjectIdResponse(id=1234897, encodeId=f07d123489e0a, content=审稿速度:24.0 | 投稿命中率:5.0 偏重的研究方向：111 经验分享：1111, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=120b6405718, createdName=ms7000000694942772, createdTime=Tue Jul 26 16:12:06 CST 2022, time=2022-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226722, encodeId=8f511226e22e8, content=6-9写了撤稿信，系统回复十天左右会回复邮件，后面又发过撤稿信，被网易退回邮件，互动评审已经激活，出现了三个审稿人，有两人提了一点拼写，增加参考文献要求然后结束审稿，有一个提了十条修改意见，让我修回，我到底该咋办，预警期刊资源不报版面费。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ebd8125048, createdName=茂茂梧桐, createdTime=Thu Jun 16 07:07:43 CST 2022, time=2022-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1201753, encodeId=7ca11201e53f5, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：流行病学 经验分享：文章接受了，但是上预警期刊了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=df116455260, createdName=ms3000000556942775, createdTime=Fri Mar 11 18:36:13 CST 2022, time=2022-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212720, encodeId=33a61212e2003, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：临床研究 经验分享：审稿速度快，可能是题目比较符合审稿人口味，一个小修，一个接受，感觉预警没影响，还是比较香的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0de5602870, createdName=吉非替尼子, createdTime=Tue Apr 19 23:55:29 CST 2022, time=2022-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208726, encodeId=df4e1208e2672, content=审稿速度:1.0 | 投稿命中率:95.0 经验分享：感觉还是真香, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=40785484359, createdName=ms2000001198602593, createdTime=Tue Apr 05 10:58:23 CST 2022, time=2022-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207711, encodeId=14ef120e7118c, content=偏重的研究方向：临床医学 经验分享：稿件见刊近半年后惊闻上了中科院预警名单？！感觉不大理解……突然的预警有点坑人啊~ 当时投的是临床回顾性研究，三个审稿人，一个拒稿两个建议大修，编辑决定让我大修并且必须把三个审稿人的问题逐条回答，平均下来每个人提出来的问题在15条上下，而且有的问题确实很尖锐，想破脑袋才自觉勉强回答得可以。期间向编辑发邮件请求延期修回（杂志社给的时间太紧了只放半个月），对方也很nice地同意延长到一个月。从投稿到接收大概花了有4个月左右。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26fc5490985, createdName=ms5000001509020786, createdTime=Fri Apr 01 00:32:35 CST 2022, time=2022-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084388, encodeId=ec6b10843883b, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：脑卒中 经验分享：我在6.18投稿，等了2个月没有审稿，换到另一个主题，2个审稿人审了3个月，12.07接受，12.20完成proof。但是不知道多久会online？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM632og6BGtgCG36JyHOMDAz5d9M72Gojw7d2YxlmgicSQ1v7JAaZz9WxwwVKArEMvSicpuRIyEibtSsJzUQqZ9fzzuMZak2WWKAs8/0, createdBy=a63a1933845, createdName=L/风, createdTime=Sun Dec 26 12:24:05 CST 2021, time=2021-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184327, encodeId=e904118432ef4, content=Review Finailed都一个多月了编辑都没有消息，催了两次也没回。两个审稿人endorsed的都很快。这编辑也是无语了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d2595112466, createdName=1461a9cfm23暂无昵称, createdTime=Fri Jan 14 19:33:52 CST 2022, time=2022-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071114, encodeId=fa3b10e111423, content=做的纯生信的，投稿一周让转投到frontiers in Oncology ，感觉要被拒，但还是同意了，因为实在不知道哪里还能生信灌水了……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210909/7146f1426c1e49bbb98d94637759e71f/7d17fd3269ca410d895702092f504459.jpg, createdBy=ac155115075, createdName=一只虫虫, createdTime=Wed Nov 17 15:10:47 CST 2021, time=2021-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179946, encodeId=46dc11e994649, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：2021年12月31被中科院列为低度预警期刊，仔细查了一下，该杂志国人占比和自引率都比较低，上榜的原因可能是扩刊问题，2019年300左右，2020接近1000篇，2021目测2000左右，同时对比了下其他的frontiers的杂志基本都存在扩刊严重的问题。目前一篇临床小文章刚让修稿，自己想重投但老板不想撤，纠结中。不知道各位怎么看。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a5e86444183, createdName=ms8000001802186405, createdTime=Mon Jan 03 09:52:08 CST 2022, time=2022-01-03, status=1, ipAttribution=)]

2022-06-16 茂茂梧桐

6-9写了撤稿信，系统回复十天左右会回复邮件，后面又发过撤稿信，被网易退回邮件，互动评审已经激活，出现了三个审稿人，有两人提了一点拼写，增加参考文献要求然后结束审稿，有一个提了十条修改意见，让我修回，我到底该咋办，预警期刊资源不报版面费。。。

63 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=1234897, encodeId=f07d123489e0a, content=审稿速度:24.0 | 投稿命中率:5.0 偏重的研究方向：111 经验分享：1111, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=120b6405718, createdName=ms7000000694942772, createdTime=Tue Jul 26 16:12:06 CST 2022, time=2022-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226722, encodeId=8f511226e22e8, content=6-9写了撤稿信，系统回复十天左右会回复邮件，后面又发过撤稿信，被网易退回邮件，互动评审已经激活，出现了三个审稿人，有两人提了一点拼写，增加参考文献要求然后结束审稿，有一个提了十条修改意见，让我修回，我到底该咋办，预警期刊资源不报版面费。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ebd8125048, createdName=茂茂梧桐, createdTime=Thu Jun 16 07:07:43 CST 2022, time=2022-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1201753, encodeId=7ca11201e53f5, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：流行病学 经验分享：文章接受了，但是上预警期刊了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=df116455260, createdName=ms3000000556942775, createdTime=Fri Mar 11 18:36:13 CST 2022, time=2022-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212720, encodeId=33a61212e2003, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：临床研究 经验分享：审稿速度快，可能是题目比较符合审稿人口味，一个小修，一个接受，感觉预警没影响，还是比较香的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0de5602870, createdName=吉非替尼子, createdTime=Tue Apr 19 23:55:29 CST 2022, time=2022-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208726, encodeId=df4e1208e2672, content=审稿速度:1.0 | 投稿命中率:95.0 经验分享：感觉还是真香, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=40785484359, createdName=ms2000001198602593, createdTime=Tue Apr 05 10:58:23 CST 2022, time=2022-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207711, encodeId=14ef120e7118c, content=偏重的研究方向：临床医学 经验分享：稿件见刊近半年后惊闻上了中科院预警名单？！感觉不大理解……突然的预警有点坑人啊~ 当时投的是临床回顾性研究，三个审稿人，一个拒稿两个建议大修，编辑决定让我大修并且必须把三个审稿人的问题逐条回答，平均下来每个人提出来的问题在15条上下，而且有的问题确实很尖锐，想破脑袋才自觉勉强回答得可以。期间向编辑发邮件请求延期修回（杂志社给的时间太紧了只放半个月），对方也很nice地同意延长到一个月。从投稿到接收大概花了有4个月左右。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26fc5490985, createdName=ms5000001509020786, createdTime=Fri Apr 01 00:32:35 CST 2022, time=2022-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084388, encodeId=ec6b10843883b, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：脑卒中 经验分享：我在6.18投稿，等了2个月没有审稿，换到另一个主题，2个审稿人审了3个月，12.07接受，12.20完成proof。但是不知道多久会online？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM632og6BGtgCG36JyHOMDAz5d9M72Gojw7d2YxlmgicSQ1v7JAaZz9WxwwVKArEMvSicpuRIyEibtSsJzUQqZ9fzzuMZak2WWKAs8/0, createdBy=a63a1933845, createdName=L/风, createdTime=Sun Dec 26 12:24:05 CST 2021, time=2021-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184327, encodeId=e904118432ef4, content=Review Finailed都一个多月了编辑都没有消息，催了两次也没回。两个审稿人endorsed的都很快。这编辑也是无语了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d2595112466, createdName=1461a9cfm23暂无昵称, createdTime=Fri Jan 14 19:33:52 CST 2022, time=2022-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071114, encodeId=fa3b10e111423, content=做的纯生信的，投稿一周让转投到frontiers in Oncology ，感觉要被拒，但还是同意了，因为实在不知道哪里还能生信灌水了……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210909/7146f1426c1e49bbb98d94637759e71f/7d17fd3269ca410d895702092f504459.jpg, createdBy=ac155115075, createdName=一只虫虫, createdTime=Wed Nov 17 15:10:47 CST 2021, time=2021-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179946, encodeId=46dc11e994649, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：2021年12月31被中科院列为低度预警期刊，仔细查了一下，该杂志国人占比和自引率都比较低，上榜的原因可能是扩刊问题，2019年300左右，2020接近1000篇，2021目测2000左右，同时对比了下其他的frontiers的杂志基本都存在扩刊严重的问题。目前一篇临床小文章刚让修稿，自己想重投但老板不想撤，纠结中。不知道各位怎么看。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a5e86444183, createdName=ms8000001802186405, createdTime=Mon Jan 03 09:52:08 CST 2022, time=2022-01-03, status=1, ipAttribution=)]

2022-03-11 ms3000000556942775

审稿速度:6.0 | 投稿命中率:50.0
偏重的研究方向：流行病学
经验分享：文章接受了，但是上预警期刊了

80 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=1234897, encodeId=f07d123489e0a, content=审稿速度:24.0 | 投稿命中率:5.0 偏重的研究方向：111 经验分享：1111, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=120b6405718, createdName=ms7000000694942772, createdTime=Tue Jul 26 16:12:06 CST 2022, time=2022-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226722, encodeId=8f511226e22e8, content=6-9写了撤稿信，系统回复十天左右会回复邮件，后面又发过撤稿信，被网易退回邮件，互动评审已经激活，出现了三个审稿人，有两人提了一点拼写，增加参考文献要求然后结束审稿，有一个提了十条修改意见，让我修回，我到底该咋办，预警期刊资源不报版面费。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ebd8125048, createdName=茂茂梧桐, createdTime=Thu Jun 16 07:07:43 CST 2022, time=2022-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1201753, encodeId=7ca11201e53f5, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：流行病学 经验分享：文章接受了，但是上预警期刊了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=df116455260, createdName=ms3000000556942775, createdTime=Fri Mar 11 18:36:13 CST 2022, time=2022-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212720, encodeId=33a61212e2003, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：临床研究 经验分享：审稿速度快，可能是题目比较符合审稿人口味，一个小修，一个接受，感觉预警没影响，还是比较香的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0de5602870, createdName=吉非替尼子, createdTime=Tue Apr 19 23:55:29 CST 2022, time=2022-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208726, encodeId=df4e1208e2672, content=审稿速度:1.0 | 投稿命中率:95.0 经验分享：感觉还是真香, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=40785484359, createdName=ms2000001198602593, createdTime=Tue Apr 05 10:58:23 CST 2022, time=2022-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207711, encodeId=14ef120e7118c, content=偏重的研究方向：临床医学 经验分享：稿件见刊近半年后惊闻上了中科院预警名单？！感觉不大理解……突然的预警有点坑人啊~ 当时投的是临床回顾性研究，三个审稿人，一个拒稿两个建议大修，编辑决定让我大修并且必须把三个审稿人的问题逐条回答，平均下来每个人提出来的问题在15条上下，而且有的问题确实很尖锐，想破脑袋才自觉勉强回答得可以。期间向编辑发邮件请求延期修回（杂志社给的时间太紧了只放半个月），对方也很nice地同意延长到一个月。从投稿到接收大概花了有4个月左右。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26fc5490985, createdName=ms5000001509020786, createdTime=Fri Apr 01 00:32:35 CST 2022, time=2022-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084388, encodeId=ec6b10843883b, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：脑卒中 经验分享：我在6.18投稿，等了2个月没有审稿，换到另一个主题，2个审稿人审了3个月，12.07接受，12.20完成proof。但是不知道多久会online？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM632og6BGtgCG36JyHOMDAz5d9M72Gojw7d2YxlmgicSQ1v7JAaZz9WxwwVKArEMvSicpuRIyEibtSsJzUQqZ9fzzuMZak2WWKAs8/0, createdBy=a63a1933845, createdName=L/风, createdTime=Sun Dec 26 12:24:05 CST 2021, time=2021-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184327, encodeId=e904118432ef4, content=Review Finailed都一个多月了编辑都没有消息，催了两次也没回。两个审稿人endorsed的都很快。这编辑也是无语了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d2595112466, createdName=1461a9cfm23暂无昵称, createdTime=Fri Jan 14 19:33:52 CST 2022, time=2022-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071114, encodeId=fa3b10e111423, content=做的纯生信的，投稿一周让转投到frontiers in Oncology ，感觉要被拒，但还是同意了，因为实在不知道哪里还能生信灌水了……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210909/7146f1426c1e49bbb98d94637759e71f/7d17fd3269ca410d895702092f504459.jpg, createdBy=ac155115075, createdName=一只虫虫, createdTime=Wed Nov 17 15:10:47 CST 2021, time=2021-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179946, encodeId=46dc11e994649, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：2021年12月31被中科院列为低度预警期刊，仔细查了一下，该杂志国人占比和自引率都比较低，上榜的原因可能是扩刊问题，2019年300左右，2020接近1000篇，2021目测2000左右，同时对比了下其他的frontiers的杂志基本都存在扩刊严重的问题。目前一篇临床小文章刚让修稿，自己想重投但老板不想撤，纠结中。不知道各位怎么看。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a5e86444183, createdName=ms8000001802186405, createdTime=Mon Jan 03 09:52:08 CST 2022, time=2022-01-03, status=1, ipAttribution=)]

2022-04-19 吉非替尼子

审稿速度:1.0 | 投稿命中率:50.0
偏重的研究方向：临床研究
经验分享：审稿速度快，可能是题目比较符合审稿人口味，一个小修，一个接受，感觉预警没影响，还是比较香的。

53 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1234897, encodeId=f07d123489e0a, content=审稿速度:24.0 | 投稿命中率:5.0 偏重的研究方向：111 经验分享：1111, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=120b6405718, createdName=ms7000000694942772, createdTime=Tue Jul 26 16:12:06 CST 2022, time=2022-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226722, encodeId=8f511226e22e8, content=6-9写了撤稿信，系统回复十天左右会回复邮件，后面又发过撤稿信，被网易退回邮件，互动评审已经激活，出现了三个审稿人，有两人提了一点拼写，增加参考文献要求然后结束审稿，有一个提了十条修改意见，让我修回，我到底该咋办，预警期刊资源不报版面费。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ebd8125048, createdName=茂茂梧桐, createdTime=Thu Jun 16 07:07:43 CST 2022, time=2022-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1201753, encodeId=7ca11201e53f5, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：流行病学 经验分享：文章接受了，但是上预警期刊了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=df116455260, createdName=ms3000000556942775, createdTime=Fri Mar 11 18:36:13 CST 2022, time=2022-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212720, encodeId=33a61212e2003, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：临床研究 经验分享：审稿速度快，可能是题目比较符合审稿人口味，一个小修，一个接受，感觉预警没影响，还是比较香的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0de5602870, createdName=吉非替尼子, createdTime=Tue Apr 19 23:55:29 CST 2022, time=2022-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208726, encodeId=df4e1208e2672, content=审稿速度:1.0 | 投稿命中率:95.0 经验分享：感觉还是真香, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=40785484359, createdName=ms2000001198602593, createdTime=Tue Apr 05 10:58:23 CST 2022, time=2022-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207711, encodeId=14ef120e7118c, content=偏重的研究方向：临床医学 经验分享：稿件见刊近半年后惊闻上了中科院预警名单？！感觉不大理解……突然的预警有点坑人啊~ 当时投的是临床回顾性研究，三个审稿人，一个拒稿两个建议大修，编辑决定让我大修并且必须把三个审稿人的问题逐条回答，平均下来每个人提出来的问题在15条上下，而且有的问题确实很尖锐，想破脑袋才自觉勉强回答得可以。期间向编辑发邮件请求延期修回（杂志社给的时间太紧了只放半个月），对方也很nice地同意延长到一个月。从投稿到接收大概花了有4个月左右。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26fc5490985, createdName=ms5000001509020786, createdTime=Fri Apr 01 00:32:35 CST 2022, time=2022-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084388, encodeId=ec6b10843883b, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：脑卒中 经验分享：我在6.18投稿，等了2个月没有审稿，换到另一个主题，2个审稿人审了3个月，12.07接受，12.20完成proof。但是不知道多久会online？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM632og6BGtgCG36JyHOMDAz5d9M72Gojw7d2YxlmgicSQ1v7JAaZz9WxwwVKArEMvSicpuRIyEibtSsJzUQqZ9fzzuMZak2WWKAs8/0, createdBy=a63a1933845, createdName=L/风, createdTime=Sun Dec 26 12:24:05 CST 2021, time=2021-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184327, encodeId=e904118432ef4, content=Review Finailed都一个多月了编辑都没有消息，催了两次也没回。两个审稿人endorsed的都很快。这编辑也是无语了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d2595112466, createdName=1461a9cfm23暂无昵称, createdTime=Fri Jan 14 19:33:52 CST 2022, time=2022-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071114, encodeId=fa3b10e111423, content=做的纯生信的，投稿一周让转投到frontiers in Oncology ，感觉要被拒，但还是同意了，因为实在不知道哪里还能生信灌水了……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210909/7146f1426c1e49bbb98d94637759e71f/7d17fd3269ca410d895702092f504459.jpg, createdBy=ac155115075, createdName=一只虫虫, createdTime=Wed Nov 17 15:10:47 CST 2021, time=2021-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179946, encodeId=46dc11e994649, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：2021年12月31被中科院列为低度预警期刊，仔细查了一下，该杂志国人占比和自引率都比较低，上榜的原因可能是扩刊问题，2019年300左右，2020接近1000篇，2021目测2000左右，同时对比了下其他的frontiers的杂志基本都存在扩刊严重的问题。目前一篇临床小文章刚让修稿，自己想重投但老板不想撤，纠结中。不知道各位怎么看。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a5e86444183, createdName=ms8000001802186405, createdTime=Mon Jan 03 09:52:08 CST 2022, time=2022-01-03, status=1, ipAttribution=)]

2022-04-05 ms2000001198602593

审稿速度:1.0 | 投稿命中率:95.0
经验分享：感觉还是真香

59 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1234897, encodeId=f07d123489e0a, content=审稿速度:24.0 | 投稿命中率:5.0 偏重的研究方向：111 经验分享：1111, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=120b6405718, createdName=ms7000000694942772, createdTime=Tue Jul 26 16:12:06 CST 2022, time=2022-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226722, encodeId=8f511226e22e8, content=6-9写了撤稿信，系统回复十天左右会回复邮件，后面又发过撤稿信，被网易退回邮件，互动评审已经激活，出现了三个审稿人，有两人提了一点拼写，增加参考文献要求然后结束审稿，有一个提了十条修改意见，让我修回，我到底该咋办，预警期刊资源不报版面费。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ebd8125048, createdName=茂茂梧桐, createdTime=Thu Jun 16 07:07:43 CST 2022, time=2022-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1201753, encodeId=7ca11201e53f5, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：流行病学 经验分享：文章接受了，但是上预警期刊了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=df116455260, createdName=ms3000000556942775, createdTime=Fri Mar 11 18:36:13 CST 2022, time=2022-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212720, encodeId=33a61212e2003, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：临床研究 经验分享：审稿速度快，可能是题目比较符合审稿人口味，一个小修，一个接受，感觉预警没影响，还是比较香的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0de5602870, createdName=吉非替尼子, createdTime=Tue Apr 19 23:55:29 CST 2022, time=2022-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208726, encodeId=df4e1208e2672, content=审稿速度:1.0 | 投稿命中率:95.0 经验分享：感觉还是真香, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=40785484359, createdName=ms2000001198602593, createdTime=Tue Apr 05 10:58:23 CST 2022, time=2022-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207711, encodeId=14ef120e7118c, content=偏重的研究方向：临床医学 经验分享：稿件见刊近半年后惊闻上了中科院预警名单？！感觉不大理解……突然的预警有点坑人啊~ 当时投的是临床回顾性研究，三个审稿人，一个拒稿两个建议大修，编辑决定让我大修并且必须把三个审稿人的问题逐条回答，平均下来每个人提出来的问题在15条上下，而且有的问题确实很尖锐，想破脑袋才自觉勉强回答得可以。期间向编辑发邮件请求延期修回（杂志社给的时间太紧了只放半个月），对方也很nice地同意延长到一个月。从投稿到接收大概花了有4个月左右。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26fc5490985, createdName=ms5000001509020786, createdTime=Fri Apr 01 00:32:35 CST 2022, time=2022-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084388, encodeId=ec6b10843883b, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：脑卒中 经验分享：我在6.18投稿，等了2个月没有审稿，换到另一个主题，2个审稿人审了3个月，12.07接受，12.20完成proof。但是不知道多久会online？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM632og6BGtgCG36JyHOMDAz5d9M72Gojw7d2YxlmgicSQ1v7JAaZz9WxwwVKArEMvSicpuRIyEibtSsJzUQqZ9fzzuMZak2WWKAs8/0, createdBy=a63a1933845, createdName=L/风, createdTime=Sun Dec 26 12:24:05 CST 2021, time=2021-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184327, encodeId=e904118432ef4, content=Review Finailed都一个多月了编辑都没有消息，催了两次也没回。两个审稿人endorsed的都很快。这编辑也是无语了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d2595112466, createdName=1461a9cfm23暂无昵称, createdTime=Fri Jan 14 19:33:52 CST 2022, time=2022-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071114, encodeId=fa3b10e111423, content=做的纯生信的，投稿一周让转投到frontiers in Oncology ，感觉要被拒，但还是同意了，因为实在不知道哪里还能生信灌水了……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210909/7146f1426c1e49bbb98d94637759e71f/7d17fd3269ca410d895702092f504459.jpg, createdBy=ac155115075, createdName=一只虫虫, createdTime=Wed Nov 17 15:10:47 CST 2021, time=2021-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179946, encodeId=46dc11e994649, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：2021年12月31被中科院列为低度预警期刊，仔细查了一下，该杂志国人占比和自引率都比较低，上榜的原因可能是扩刊问题，2019年300左右，2020接近1000篇，2021目测2000左右，同时对比了下其他的frontiers的杂志基本都存在扩刊严重的问题。目前一篇临床小文章刚让修稿，自己想重投但老板不想撤，纠结中。不知道各位怎么看。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a5e86444183, createdName=ms8000001802186405, createdTime=Mon Jan 03 09:52:08 CST 2022, time=2022-01-03, status=1, ipAttribution=)]

2022-04-01 ms5000001509020786

偏重的研究方向：临床医学
经验分享：稿件见刊近半年后惊闻上了中科院预警名单？！感觉不大理解……突然的预警有点坑人啊~

当时投的是临床回顾性研究，三个审稿人，一个拒稿两个建议大修，编辑决定让我大修并且必须把三个审稿人的问题逐条回答，平均下来每个人提出来的问题在15条上下，而且有的问题确实很尖锐，想破脑袋才自觉勉强回答得可以。期间向编辑发邮件请求延期修回（杂志社给的时间太紧了只放半个月），对方也很nice地同意延长到一个月。从投稿到接收大概花了有4个月左右。

49 0

[GetPortalCommentsPageByObjectIdResponse(id=1234897, encodeId=f07d123489e0a, content=审稿速度:24.0 | 投稿命中率:5.0 偏重的研究方向：111 经验分享：1111, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=120b6405718, createdName=ms7000000694942772, createdTime=Tue Jul 26 16:12:06 CST 2022, time=2022-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226722, encodeId=8f511226e22e8, content=6-9写了撤稿信，系统回复十天左右会回复邮件，后面又发过撤稿信，被网易退回邮件，互动评审已经激活，出现了三个审稿人，有两人提了一点拼写，增加参考文献要求然后结束审稿，有一个提了十条修改意见，让我修回，我到底该咋办，预警期刊资源不报版面费。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ebd8125048, createdName=茂茂梧桐, createdTime=Thu Jun 16 07:07:43 CST 2022, time=2022-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1201753, encodeId=7ca11201e53f5, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：流行病学 经验分享：文章接受了，但是上预警期刊了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=df116455260, createdName=ms3000000556942775, createdTime=Fri Mar 11 18:36:13 CST 2022, time=2022-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212720, encodeId=33a61212e2003, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：临床研究 经验分享：审稿速度快，可能是题目比较符合审稿人口味，一个小修，一个接受，感觉预警没影响，还是比较香的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0de5602870, createdName=吉非替尼子, createdTime=Tue Apr 19 23:55:29 CST 2022, time=2022-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208726, encodeId=df4e1208e2672, content=审稿速度:1.0 | 投稿命中率:95.0 经验分享：感觉还是真香, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=40785484359, createdName=ms2000001198602593, createdTime=Tue Apr 05 10:58:23 CST 2022, time=2022-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207711, encodeId=14ef120e7118c, content=偏重的研究方向：临床医学 经验分享：稿件见刊近半年后惊闻上了中科院预警名单？！感觉不大理解……突然的预警有点坑人啊~ 当时投的是临床回顾性研究，三个审稿人，一个拒稿两个建议大修，编辑决定让我大修并且必须把三个审稿人的问题逐条回答，平均下来每个人提出来的问题在15条上下，而且有的问题确实很尖锐，想破脑袋才自觉勉强回答得可以。期间向编辑发邮件请求延期修回（杂志社给的时间太紧了只放半个月），对方也很nice地同意延长到一个月。从投稿到接收大概花了有4个月左右。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26fc5490985, createdName=ms5000001509020786, createdTime=Fri Apr 01 00:32:35 CST 2022, time=2022-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084388, encodeId=ec6b10843883b, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：脑卒中 经验分享：我在6.18投稿，等了2个月没有审稿，换到另一个主题，2个审稿人审了3个月，12.07接受，12.20完成proof。但是不知道多久会online？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM632og6BGtgCG36JyHOMDAz5d9M72Gojw7d2YxlmgicSQ1v7JAaZz9WxwwVKArEMvSicpuRIyEibtSsJzUQqZ9fzzuMZak2WWKAs8/0, createdBy=a63a1933845, createdName=L/风, createdTime=Sun Dec 26 12:24:05 CST 2021, time=2021-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184327, encodeId=e904118432ef4, content=Review Finailed都一个多月了编辑都没有消息，催了两次也没回。两个审稿人endorsed的都很快。这编辑也是无语了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d2595112466, createdName=1461a9cfm23暂无昵称, createdTime=Fri Jan 14 19:33:52 CST 2022, time=2022-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071114, encodeId=fa3b10e111423, content=做的纯生信的，投稿一周让转投到frontiers in Oncology ，感觉要被拒，但还是同意了，因为实在不知道哪里还能生信灌水了……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210909/7146f1426c1e49bbb98d94637759e71f/7d17fd3269ca410d895702092f504459.jpg, createdBy=ac155115075, createdName=一只虫虫, createdTime=Wed Nov 17 15:10:47 CST 2021, time=2021-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179946, encodeId=46dc11e994649, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：2021年12月31被中科院列为低度预警期刊，仔细查了一下，该杂志国人占比和自引率都比较低，上榜的原因可能是扩刊问题，2019年300左右，2020接近1000篇，2021目测2000左右，同时对比了下其他的frontiers的杂志基本都存在扩刊严重的问题。目前一篇临床小文章刚让修稿，自己想重投但老板不想撤，纠结中。不知道各位怎么看。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a5e86444183, createdName=ms8000001802186405, createdTime=Mon Jan 03 09:52:08 CST 2022, time=2022-01-03, status=1, ipAttribution=)]

2021-12-26 L/风

审稿速度:6.0 | 投稿命中率:50.0
偏重的研究方向：脑卒中
经验分享：我在6.18投稿，等了2个月没有审稿，换到另一个主题，2个审稿人审了3个月，12.07接受，12.20完成proof。但是不知道多久会online？

73 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=1234897, encodeId=f07d123489e0a, content=审稿速度:24.0 | 投稿命中率:5.0 偏重的研究方向：111 经验分享：1111, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=120b6405718, createdName=ms7000000694942772, createdTime=Tue Jul 26 16:12:06 CST 2022, time=2022-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226722, encodeId=8f511226e22e8, content=6-9写了撤稿信，系统回复十天左右会回复邮件，后面又发过撤稿信，被网易退回邮件，互动评审已经激活，出现了三个审稿人，有两人提了一点拼写，增加参考文献要求然后结束审稿，有一个提了十条修改意见，让我修回，我到底该咋办，预警期刊资源不报版面费。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ebd8125048, createdName=茂茂梧桐, createdTime=Thu Jun 16 07:07:43 CST 2022, time=2022-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1201753, encodeId=7ca11201e53f5, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：流行病学 经验分享：文章接受了，但是上预警期刊了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=df116455260, createdName=ms3000000556942775, createdTime=Fri Mar 11 18:36:13 CST 2022, time=2022-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212720, encodeId=33a61212e2003, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：临床研究 经验分享：审稿速度快，可能是题目比较符合审稿人口味，一个小修，一个接受，感觉预警没影响，还是比较香的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0de5602870, createdName=吉非替尼子, createdTime=Tue Apr 19 23:55:29 CST 2022, time=2022-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208726, encodeId=df4e1208e2672, content=审稿速度:1.0 | 投稿命中率:95.0 经验分享：感觉还是真香, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=40785484359, createdName=ms2000001198602593, createdTime=Tue Apr 05 10:58:23 CST 2022, time=2022-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207711, encodeId=14ef120e7118c, content=偏重的研究方向：临床医学 经验分享：稿件见刊近半年后惊闻上了中科院预警名单？！感觉不大理解……突然的预警有点坑人啊~ 当时投的是临床回顾性研究，三个审稿人，一个拒稿两个建议大修，编辑决定让我大修并且必须把三个审稿人的问题逐条回答，平均下来每个人提出来的问题在15条上下，而且有的问题确实很尖锐，想破脑袋才自觉勉强回答得可以。期间向编辑发邮件请求延期修回（杂志社给的时间太紧了只放半个月），对方也很nice地同意延长到一个月。从投稿到接收大概花了有4个月左右。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26fc5490985, createdName=ms5000001509020786, createdTime=Fri Apr 01 00:32:35 CST 2022, time=2022-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084388, encodeId=ec6b10843883b, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：脑卒中 经验分享：我在6.18投稿，等了2个月没有审稿，换到另一个主题，2个审稿人审了3个月，12.07接受，12.20完成proof。但是不知道多久会online？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM632og6BGtgCG36JyHOMDAz5d9M72Gojw7d2YxlmgicSQ1v7JAaZz9WxwwVKArEMvSicpuRIyEibtSsJzUQqZ9fzzuMZak2WWKAs8/0, createdBy=a63a1933845, createdName=L/风, createdTime=Sun Dec 26 12:24:05 CST 2021, time=2021-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184327, encodeId=e904118432ef4, content=Review Finailed都一个多月了编辑都没有消息，催了两次也没回。两个审稿人endorsed的都很快。这编辑也是无语了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d2595112466, createdName=1461a9cfm23暂无昵称, createdTime=Fri Jan 14 19:33:52 CST 2022, time=2022-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071114, encodeId=fa3b10e111423, content=做的纯生信的，投稿一周让转投到frontiers in Oncology ，感觉要被拒，但还是同意了，因为实在不知道哪里还能生信灌水了……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210909/7146f1426c1e49bbb98d94637759e71f/7d17fd3269ca410d895702092f504459.jpg, createdBy=ac155115075, createdName=一只虫虫, createdTime=Wed Nov 17 15:10:47 CST 2021, time=2021-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179946, encodeId=46dc11e994649, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：2021年12月31被中科院列为低度预警期刊，仔细查了一下，该杂志国人占比和自引率都比较低，上榜的原因可能是扩刊问题，2019年300左右，2020接近1000篇，2021目测2000左右，同时对比了下其他的frontiers的杂志基本都存在扩刊严重的问题。目前一篇临床小文章刚让修稿，自己想重投但老板不想撤，纠结中。不知道各位怎么看。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a5e86444183, createdName=ms8000001802186405, createdTime=Mon Jan 03 09:52:08 CST 2022, time=2022-01-03, status=1, ipAttribution=)]

2022-01-14 1461a9cfm23暂无昵称

Review Finailed都一个多月了编辑都没有消息，催了两次也没回。两个审稿人endorsed的都很快。这编辑也是无语了。

93 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=1234897, encodeId=f07d123489e0a, content=审稿速度:24.0 | 投稿命中率:5.0 偏重的研究方向：111 经验分享：1111, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=120b6405718, createdName=ms7000000694942772, createdTime=Tue Jul 26 16:12:06 CST 2022, time=2022-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226722, encodeId=8f511226e22e8, content=6-9写了撤稿信，系统回复十天左右会回复邮件，后面又发过撤稿信，被网易退回邮件，互动评审已经激活，出现了三个审稿人，有两人提了一点拼写，增加参考文献要求然后结束审稿，有一个提了十条修改意见，让我修回，我到底该咋办，预警期刊资源不报版面费。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ebd8125048, createdName=茂茂梧桐, createdTime=Thu Jun 16 07:07:43 CST 2022, time=2022-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1201753, encodeId=7ca11201e53f5, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：流行病学 经验分享：文章接受了，但是上预警期刊了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=df116455260, createdName=ms3000000556942775, createdTime=Fri Mar 11 18:36:13 CST 2022, time=2022-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212720, encodeId=33a61212e2003, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：临床研究 经验分享：审稿速度快，可能是题目比较符合审稿人口味，一个小修，一个接受，感觉预警没影响，还是比较香的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0de5602870, createdName=吉非替尼子, createdTime=Tue Apr 19 23:55:29 CST 2022, time=2022-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208726, encodeId=df4e1208e2672, content=审稿速度:1.0 | 投稿命中率:95.0 经验分享：感觉还是真香, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=40785484359, createdName=ms2000001198602593, createdTime=Tue Apr 05 10:58:23 CST 2022, time=2022-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207711, encodeId=14ef120e7118c, content=偏重的研究方向：临床医学 经验分享：稿件见刊近半年后惊闻上了中科院预警名单？！感觉不大理解……突然的预警有点坑人啊~ 当时投的是临床回顾性研究，三个审稿人，一个拒稿两个建议大修，编辑决定让我大修并且必须把三个审稿人的问题逐条回答，平均下来每个人提出来的问题在15条上下，而且有的问题确实很尖锐，想破脑袋才自觉勉强回答得可以。期间向编辑发邮件请求延期修回（杂志社给的时间太紧了只放半个月），对方也很nice地同意延长到一个月。从投稿到接收大概花了有4个月左右。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26fc5490985, createdName=ms5000001509020786, createdTime=Fri Apr 01 00:32:35 CST 2022, time=2022-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084388, encodeId=ec6b10843883b, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：脑卒中 经验分享：我在6.18投稿，等了2个月没有审稿，换到另一个主题，2个审稿人审了3个月，12.07接受，12.20完成proof。但是不知道多久会online？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM632og6BGtgCG36JyHOMDAz5d9M72Gojw7d2YxlmgicSQ1v7JAaZz9WxwwVKArEMvSicpuRIyEibtSsJzUQqZ9fzzuMZak2WWKAs8/0, createdBy=a63a1933845, createdName=L/风, createdTime=Sun Dec 26 12:24:05 CST 2021, time=2021-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184327, encodeId=e904118432ef4, content=Review Finailed都一个多月了编辑都没有消息，催了两次也没回。两个审稿人endorsed的都很快。这编辑也是无语了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d2595112466, createdName=1461a9cfm23暂无昵称, createdTime=Fri Jan 14 19:33:52 CST 2022, time=2022-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071114, encodeId=fa3b10e111423, content=做的纯生信的，投稿一周让转投到frontiers in Oncology ，感觉要被拒，但还是同意了，因为实在不知道哪里还能生信灌水了……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210909/7146f1426c1e49bbb98d94637759e71f/7d17fd3269ca410d895702092f504459.jpg, createdBy=ac155115075, createdName=一只虫虫, createdTime=Wed Nov 17 15:10:47 CST 2021, time=2021-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179946, encodeId=46dc11e994649, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：2021年12月31被中科院列为低度预警期刊，仔细查了一下，该杂志国人占比和自引率都比较低，上榜的原因可能是扩刊问题，2019年300左右，2020接近1000篇，2021目测2000左右，同时对比了下其他的frontiers的杂志基本都存在扩刊严重的问题。目前一篇临床小文章刚让修稿，自己想重投但老板不想撤，纠结中。不知道各位怎么看。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a5e86444183, createdName=ms8000001802186405, createdTime=Mon Jan 03 09:52:08 CST 2022, time=2022-01-03, status=1, ipAttribution=)]

2021-11-17 一只虫虫

做的纯生信的，投稿一周让转投到frontiers in Oncology ，感觉要被拒，但还是同意了，因为实在不知道哪里还能生信灌水了……

74 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=1234897, encodeId=f07d123489e0a, content=审稿速度:24.0 | 投稿命中率:5.0 偏重的研究方向：111 经验分享：1111, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=120b6405718, createdName=ms7000000694942772, createdTime=Tue Jul 26 16:12:06 CST 2022, time=2022-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226722, encodeId=8f511226e22e8, content=6-9写了撤稿信，系统回复十天左右会回复邮件，后面又发过撤稿信，被网易退回邮件，互动评审已经激活，出现了三个审稿人，有两人提了一点拼写，增加参考文献要求然后结束审稿，有一个提了十条修改意见，让我修回，我到底该咋办，预警期刊资源不报版面费。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ebd8125048, createdName=茂茂梧桐, createdTime=Thu Jun 16 07:07:43 CST 2022, time=2022-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1201753, encodeId=7ca11201e53f5, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：流行病学 经验分享：文章接受了，但是上预警期刊了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=df116455260, createdName=ms3000000556942775, createdTime=Fri Mar 11 18:36:13 CST 2022, time=2022-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212720, encodeId=33a61212e2003, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：临床研究 经验分享：审稿速度快，可能是题目比较符合审稿人口味，一个小修，一个接受，感觉预警没影响，还是比较香的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0de5602870, createdName=吉非替尼子, createdTime=Tue Apr 19 23:55:29 CST 2022, time=2022-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208726, encodeId=df4e1208e2672, content=审稿速度:1.0 | 投稿命中率:95.0 经验分享：感觉还是真香, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=40785484359, createdName=ms2000001198602593, createdTime=Tue Apr 05 10:58:23 CST 2022, time=2022-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207711, encodeId=14ef120e7118c, content=偏重的研究方向：临床医学 经验分享：稿件见刊近半年后惊闻上了中科院预警名单？！感觉不大理解……突然的预警有点坑人啊~ 当时投的是临床回顾性研究，三个审稿人，一个拒稿两个建议大修，编辑决定让我大修并且必须把三个审稿人的问题逐条回答，平均下来每个人提出来的问题在15条上下，而且有的问题确实很尖锐，想破脑袋才自觉勉强回答得可以。期间向编辑发邮件请求延期修回（杂志社给的时间太紧了只放半个月），对方也很nice地同意延长到一个月。从投稿到接收大概花了有4个月左右。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26fc5490985, createdName=ms5000001509020786, createdTime=Fri Apr 01 00:32:35 CST 2022, time=2022-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084388, encodeId=ec6b10843883b, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：脑卒中 经验分享：我在6.18投稿，等了2个月没有审稿，换到另一个主题，2个审稿人审了3个月，12.07接受，12.20完成proof。但是不知道多久会online？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM632og6BGtgCG36JyHOMDAz5d9M72Gojw7d2YxlmgicSQ1v7JAaZz9WxwwVKArEMvSicpuRIyEibtSsJzUQqZ9fzzuMZak2WWKAs8/0, createdBy=a63a1933845, createdName=L/风, createdTime=Sun Dec 26 12:24:05 CST 2021, time=2021-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184327, encodeId=e904118432ef4, content=Review Finailed都一个多月了编辑都没有消息，催了两次也没回。两个审稿人endorsed的都很快。这编辑也是无语了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d2595112466, createdName=1461a9cfm23暂无昵称, createdTime=Fri Jan 14 19:33:52 CST 2022, time=2022-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071114, encodeId=fa3b10e111423, content=做的纯生信的，投稿一周让转投到frontiers in Oncology ，感觉要被拒，但还是同意了，因为实在不知道哪里还能生信灌水了……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210909/7146f1426c1e49bbb98d94637759e71f/7d17fd3269ca410d895702092f504459.jpg, createdBy=ac155115075, createdName=一只虫虫, createdTime=Wed Nov 17 15:10:47 CST 2021, time=2021-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179946, encodeId=46dc11e994649, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：2021年12月31被中科院列为低度预警期刊，仔细查了一下，该杂志国人占比和自引率都比较低，上榜的原因可能是扩刊问题，2019年300左右，2020接近1000篇，2021目测2000左右，同时对比了下其他的frontiers的杂志基本都存在扩刊严重的问题。目前一篇临床小文章刚让修稿，自己想重投但老板不想撤，纠结中。不知道各位怎么看。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a5e86444183, createdName=ms8000001802186405, createdTime=Mon Jan 03 09:52:08 CST 2022, time=2022-01-03, status=1, ipAttribution=)]

2022-01-03 ms8000001802186405

审稿速度:1.0 | 投稿命中率:75.0
经验分享：2021年12月31被中科院列为低度预警期刊，仔细查了一下，该杂志国人占比和自引率都比较低，上榜的原因可能是扩刊问题，2019年300左右，2020接近1000篇，2021目测2000左右，同时对比了下其他的frontiers的杂志基本都存在扩刊严重的问题。目前一篇临床小文章刚让修稿，自己想重投但老板不想撤，纠结中。不知道各位怎么看。

80 4

展开4条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务